GeneDx Holdings Corp. (WGS) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Healthcare Information Services Branche. Der Hauptsitz des Unternehmens ist in Stamford, CT, United States. Der aktuelle CEO ist Katherine A. Stueland.
WGS hat IPO-Datum 2020-11-04, 1,000 Vollzeitbeschäftigte, gelistet an der NASDAQ Global Market, eine Marktkapitalisierung von $1.98B.
GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.
